ETTX - Entasis Therapeutics EPS beats by $0.13 November, 05 2020 05:05 PM Entasis Therapeutics Holdings Inc. Entasis Therapeutics (ETTX): Q3 GAAP EPS of -$0.37 beats by $0.13. Cash, cash equivalents and short-term investments of $61.2MPress Release For further details see: Entasis Therapeutics EPS beats by $0.13